Who is sponsoring NCT03501160?

NCT03501160 is sponsored by Chinese University of Hong Kong.

What drugs are being tested in NCT03501160?

Interventions in NCT03501160: Face-to face semi-structured in-depth interview.

What condition does NCT03501160 study?

NCT03501160 studies First Episode Psychosis.

Is NCT03501160 still recruiting?

NCT03501160 is currently completed. Last updated 30 July 2021.

Last reviewed 2021-07-30 · How we verify

NCT03501160

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers' Perspective

Completed Last updated 30 July 2021

What this trial tests

trial testing Face-to face semi-structured in-depth interview in First Episode Psychosis in 8 participants. Completed in 31 October 2019.

Timeline

12 June 2018

Primary endpoint
31 October 2019

31 October 2019

Quick facts

Lead sponsor	Chinese University of Hong Kong
Status	Completed
Study type	OBSERVATIONAL
Enrollment	8
Start date	12 June 2018
Primary completion	31 October 2019
Estimated completion	31 October 2019
Sites	2 locations across Hong Kong

Drugs / interventions tested

Face-to face semi-structured in-depth interview

Conditions studied

First Episode Psychosis — all drugs for First Episode Psychosis →

Sponsor

Chinese University of Hong Kong

Who can join

Adults 18 to 64, any sex, with First Episode Psychosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Social impairment is one of the core symptoms in first episode psychosis (FEP). Despite negative symptoms and social cognition impairment found in patient suffering from FEP, clinicians occasionally identified socially inappropriate behaviours (SIB) after onset and stabilization of psychotic disorder. It is also uncommon that some caregivers often complain about their relatives with psychosis of embarrassing and immature behaviour. SIB mainly observed in form of excessive emotional expression, childish behaviour and regressive behaviour. There is limited research focusing on this inadequate behavioural pattern in patient with first episode psychosis recently. It was worth investigating this phenomenon and gain more understanding in other comorbidity symptoms and caregiving distress arisen from this. Psychometric tests and validated assessment tools are well-developed for measuring positive symptoms, negative symptoms, neurocognitive deficits and social cognition impairment in schizophrenic patients but none of them is useful specifically for assessing SIB, and not to mention, from carer's perspective. It could be an obstacle for clinicians to investigate the phenomena of the prevalence and the impact on family in real life without any validated assessment tools or questionnaires. This qualitative study aims to identify the SIB in patients with FEP and to explore the caregiving experience and distress. Hopefully, this study may help designing a questionnaire for future exploration on this topic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for First Episode Psychosis

Currently open trials in the same condition.

NCT06774417 — Digital Strategies to Advance Help-Seeking - Aim 3 · NA · recruiting
NCT06774430 — Digital Strategies to Advance Help-Seeking Aim 1 and 2 · recruiting
NCT05310838 — Optimizing Engagement in Services for First-Episode Psychosis · NA · active not recruiting
NCT04046497 — Artificial Intelligence to Measure Adherence to Oral Medication · Phase 4 · recruiting
NCT04005378 — Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs · Phase 4 · recruiting

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03501160 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 30 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03501160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing